Potential Role of iPSC Technology in Creating Exciting New Opportunities for Cardiovascular Research
Received Date: Nov 01, 2022 / Accepted Date: Nov 28, 2022 / Published Date: Nov 29, 2022
Abstract
By providing structures to learn about the mechanisms of disease pathogenesis that should result in new therapies or reveal medication sensitivities, induced pluripotent stem cell (iPSC) technology is creating exciting new opportunities for cardiovascular research. The practical relevance of iPSC-derived cardiomyocytes in drug development and toxicity testing is explored in this study, with a focus on the advancements that have already been accomplished in this area. Additionally, it highlights the crucial steps that must be accomplished before this research may be widely applied in drug discovery and toxicological evaluations.
Citation: Li Y (2022) Potential Role of iPSC Technology in Creating Exciting NewOpportunities for Cardiovascular Research. World J Pharmacol Toxicol 5: 172. Doi: 10.4172/wjpt.1000172
Copyright: © 2022 Li Y. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Select your language of interest to view the total content in your interested language
Share This Article
51ºÚÁϳԹÏÍø Journals
Article Tools
Article Usage
- Total views: 1481
- [From(publication date): 0-2022 - Jun 23, 2025]
- Breakdown by view type
- HTML page views: 1114
- PDF downloads: 367
